You may also be interested in...
Carboplatin during radiotherapy recommended exclusively in pediatric patients with high-risk group 3 medulloblastoma
Ipatasertib plus abiraterone improves survival in PTEN-negative prostate cancer patients compared to abiraterone alone
Adjuvant celecoxib not associated with improved disease-free survival in patients with ERBB2-negative breast cancer
#VisualAbstract Addition of daratumumab to standard of care improves minimal residual disease negativity in patients with newly diagnosed, transplant-ineligible multiple myeloma